Tangoe Inc. (TNGO) Jumps 7.49% on January 14

Equities Staff |

Tangoe Inc. (TNGO) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 7.49% to $8.32, representing a gain of $0.58 per share. Some 408,756 shares traded hands on 2,294 trades, compared with an average daily volume of 346,309 shares out of a total float of 39.43 million. The stock opened at $7.76 and traded with an intraday range of $8.41 to $7.75.

After today's gains, Tangoe Inc. reached a market cap of $328.06 million. Tangoe Inc. has had a trading range between $14.92 and $5.84 over the last year, and it had a 50-day SMA of $8.06 and a 200-day SMA of $10.17.

Tangoe Inc is engaged in providing connection lifecycle management software & related services to enterprises & service providers. Its matrix is an on-demand suite of software & services designed to turn on, manage, secure, & support various connections.

Tangoe Inc. is based out of Orange, CT and has some 2,339 employees. Its CEO is Albert R. Subbloie.

For a complete fundamental analysis analysis of Tangoe Inc., check out Equities.com’s Stock Valuation Analysis report for TNGO. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and…

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…